Romano Brothers & Co’s Zimmer Biomet ZBH Stock Holding History

Romano Brothers & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$681K	Hold	7,533	–	–	0.08%	199
2025 Q4	$677K	Sell	7,533 -446	-6%	-$42.3K	0.08%	199
2025 Q3	$786K	Sell	7,979 -550	-6%	-$54.5K	0.09%	187
2025 Q2	$778K	Sell	8,529 -445	-5%	-$43K	0.1%	184
2025 Q1	$1.02M	Sell	8,974 -492	-5%	-$52.6K	0.13%	157
2024 Q4	$1,000K	Buy	9,466 +102	+1%	+$10.9K	0.13%	159
2024 Q3	$1.01M	Hold	9,364	–	–	0.13%	159
2024 Q2	$1.02M	Sell	9,364 -150	-2%	-$17.7K	0.14%	150
2024 Q1	$1.26M	Buy	9,514 +100	+1%	+$12.5K	0.17%	140
2023 Q4	$1.15M	Sell	9,414 -500	-5%	-$55.8K	0.17%	137
2023 Q3	$1.11M	Hold	9,914	–	–	0.17%	141
2023 Q2	$1.44M	Sell	9,914 -125	-1%	-$17K	0.22%	122
2023 Q1	$1.3M	Hold	10,039	–	–	0.2%	125
2022 Q4	$1.28M	Sell	10,039 -150	-1%	-$17.4K	0.19%	122
2022 Q3	$1.06M	Buy	+10,189	New	+$1.12M	0.17%	136

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Romano Brothers & Co's ZBH Position: Q1 2026 in Review

Romano Brothers & Co held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 7,533 shares worth $681K. The position accounts for 0.08% of the portfolio, ranked #199.

Romano Brothers & Co first reported a position in ZBH in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.44M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Romano Brothers & Co held 7,533 shares of Zimmer Biomet worth $681K as of Q1 2026.
Romano Brothers & Co left its Zimmer Biomet share count unchanged in Q1 2026.
Zimmer Biomet made up 0.08% of Romano Brothers & Co's portfolio in Q1 2026, its #199 holding.
Romano Brothers & Co first reported a position in Zimmer Biomet in Q3 2022 and has held it in 15 quarters since.
Romano Brothers & Co's Zimmer Biomet position peaked at $1.44M in Q2 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Romano Brothers & Co's 13F filing for Q1 2026, filed 22 Apr 2026.